BackPAVmed- Warrants (29/01/2022) Overview

PAVmed- Warrants (29/01/2022) Current Cash

Track PAVmed- Warrants (29/01/2022)'s current cash ($3.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.78M
↓ 99.91% YoYΔ $-4.00B vs prior year quarter

Peer trimmed avg / median

Loading

PAVmed- Warrants (29/01/2022) Current Cash History

Loading

PAVmed- Warrants (29/01/2022) vs. peers: Current Cash Comparison

Loading

PAVmed- Warrants (29/01/2022) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PAVmed- Warrants (29/01/2022) (PAVMW) FAQ

The latest current cash for PAVMW is $3.8M as of June 2026. That compares with $4B in the prior-year period — down 99.9% year over year. Investors often review this figure alongside PAVmed- Warrants (29/01/2022)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PAVMW's current cash moved from $4B to $3.8M — a 99.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PAVmed- Warrants (29/01/2022)'s operating scale or balance-sheet position.

A current cash figure of $3.8M for PAVMW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PAVMW's current cash ($3.8M), review year-over-year change from $4B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack PAVmed- Warrants (29/01/2022)'s current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.